Pharmacological mechanism of <i>Qingfei Dayuan </i>Granules for the treatment of pneumonia by network pharmacology

GAN Dali; SHI Junfeng; YANG Suqin; XIANG Meixian

doi:10.11665/j.issn.1000-5048.20200508

Journal of China Pharmaceutical University > 2020 > 51(5): 568-576. > DOI: 10.11665/j.issn.1000-5048.20200508

GAN Dali, SHI Junfeng, YANG Suqin, XIANG Meixian. Pharmacological mechanism of Qingfei Dayuan Granules for the treatment of pneumonia by network pharmacology[J]. Journal of China Pharmaceutical University, 2020, 51(5): 568-576. DOI: 10.11665/j.issn.1000-5048.20200508

Citation:

PDF (6852 KB)

Pharmacological mechanism of Qingfei Dayuan Granules for the treatment of pneumonia by network pharmacology

Funds: This study was supported by the Natural Science Foundation of China (No.31200264) and the Fundamental Research Funds for Central Universities (No.CZY19028,No.CZY20048)

More Information

Received Date: July 07, 2020
Revised Date: September 18, 2020

Graphical Abstract

Abstract

Abstract

To explore the potential mechanism of Qinfei Dayuan Granules for the treatment of pneumonia by the network pharmacology, the potential active ingredients and drug targets of Qinfei Dayuan Granules were obtained through the Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine (TCMIP). The "component-target-disease" network and PPI network were constructed by Cytoscape 3.7.2 software, and GO functional enrichment analysis and KEGG pathway enrichment analysis were performed on the TCMIP platform to obtain a multi-dimensional network analysis of the "Chinese medicinal materials-chemical components-key targets-action pathways" and to explore the mechanism of its multi-component multi-target multi-action pathways of Qinfei Dayuan Granules for the treatment of pneumonia. A total of 474 active ingredients and 865 drug targets were identified from Qinfei Dayuan Granules; the key core targets of drugs include NF-κB, TNF-α, MAPK3, IL-1β, PTGS and CASP3, etc.. The results of GO functional enrichment analysis showed that drugs may interfere with inflammation through biological pathways such as immune regulation and apoptosis. KEGG signal pathway enrichment analysis showed that it was mainly related to the diabetic complications AGE-RAGE signaling pathway, IL-17 signaling pathway, T cell receptor signaling pathway and tumor necrosis factor signaling pathway, etc.. Qinfei Dayuan Granules can exert its effect on the treatment of pneumonia through inflammatory response and immune system with multi-ingredient, multi-target and multi-pathway pharmacological characteristics.
- Qinfei Dayuan Granules,
- network pharmacology,
- pneumonia,
- mechanism

FullText(HTML)

References (38)

References

[1]	. Suzhou：Soochow University，2018.
[2]	Suo T，Fan H，Chen GZ. Advances in the treatment of viral pneumonia［J］. Med J Wuhan Univ（武汉大学学报医学版），2020，41（3）：378?383.
[3]	Wang HD，Lin Y，Zheng JG. Distribution characteristics and drug resistance of pathogenic bacteria in sputum of lower respiratory tract in children with bacterial pneumonia［J］. J Hunan Normal Univ （Med Sci）（湖南师范大学学报医学版），2020，17（3）：146?150.
[4]	Qin X，Hu LZ. Changes of procalcitonin，C-reactive protein and D-dimer in patients with severe pneumonia and their diagnostic value for prognosis［J］. Med Recapitul （医学综述），2020，26（15）：3077?3081.
[5]	Chen WJ，Liu M，Guo SY，et al. Clinical observation 83 cases of severe pneumonia treated with Qihuang Yifei Mixture ［J］. Yunnan J Tradit Chin Med Mater Med（云南中医中药杂志），2020，41（4）：41?42.
[6]	Philippart F，Bouroche G，Timsit JF，et al. Decreased risk of ventilator-associated pneumonia in sepsis due to intra-abdominal infection［J］. PLoS One，2015，10（9）：e0137262.
[7]	Wang ZX，Fan TB. Research progress of traditional Chinese medicine in the treatment of severe pneumonia ［J］. J Emerg Tradit Chin Med（中国中医急症），2020，29（5）：930?932.
[8]	Lu YR，Ding JY，Liu QQ. Mechanism of immunologic dissonance in severe pneumonia and research progress of traditional Chinese medicine treatment ［J］. Med Pharm J Chin PLA（解放军医药杂志），2017，29（4）：45?49.
[9]	Yu XQ，Xie Y，Li JS. Guidelines for the diagnosis and treatment of community-acquired pneumonia （2018 revision）［J］. J Tradit Chin Med（中医杂志），2019，60（4）：350?360.
[10]	Qiu X. Clinical lecture notes of severe pneumonia treated by traditional Chinese medicine［J］. Chin Foreign Med Res（中外医学研究），2019，17（16）：186-188.
[11]	Sun J，Chai LX，Jing W，et al. Discussion of TCM syndrome differentiation thoughts of novel coronavirus pneumonia［J］. Tradit Chin Med Res（中医研究），2020，33（4）：1?2.
[12]	Lyu WL. Clinical ideas innovation of febrile diseases based on COVID-19［J］. J Tradit Chin Med Lit（中医文献杂志），2020，38（2）：1?4.
[13]	Xu Q，Ba YM，Li WN，et al. Discussing on qingfeidayuan granules in treating new coronary virus pneumonia based on differentiation of diseases［J］. Hubei J Tradit Chin Med（湖北中医杂志），2020，42（4）：3?6.
[14]	Wang N，Shen LL，Li H. Technology analysis on TCM hospital preparation in the prophylaxis and treatment of COVID-19［J］. China Invent Pat（中国发明与专利），2020（4）：50?54.
[15]	Wang Z，Chen YY，Zhang YY，et al. Problems and solutions in study of multi-component and multi-target mechanism of action of traditional Chinese medicine［J］. Chin J Exp Tradit Med Formulae（中国实验方剂学杂志），2018，24（5）：1?6.
[16]	Chen HB，Zhou HG，Li WT，et al. Network pharmacology：a new perspective of mechanism research of traditional Chinese medicine formula［J］. China J Tradit Chin Med Pharm（中华中医药杂志），2019，34（7）：2873?2876.
[17]	Xie J，Gao S，Li L，et al. Research progress and application strategy on network pharmacology in Chinese materia medica［J］. Chin Tradit Herb Drugs（中草药），2019，50（10）：2257?2265.
[18]	Xu HY，Zhang YQ，Liu ZM，et al. ETCM：an encyclopaedia of traditional Chinese medicine［J］. Nucleic Acids Res，2019，47（D1）：D976?D982.
[19]	Zhou SS，Li WN，Ai ZZ，et al. Study on the mechanism of Qingfei Dayuan granule in treatment of COVID-19 based on network pharmacology and molecular docking［J］. Chin Tradit Herb Drugs（中草药），2020，51（7）：1804?1813.
[20]	Peng XJ，Yang XJ，Xu G，et al. Investigating mechanism of Qingfei Dayuan granules for treatment of COVID-19 based on network pharmacology and molecular docking［J］. Chin J Exp Tradit Med Formulae（中国实验方剂学杂志），2020，26（16）：6?13.
[21]	Ma XB. Microbiological analysis and selection of antibiotic on severe pneumonia infection ［J］. Chin J Clin Ration Drug Use（临床合理用药杂志），2018，11（2）：90?92.
[22]	Huang L，Zheng YJ，Yang WG，et al. Etiological analysis of 774 cases of severe pneumonia in the area of Shenzhen ［J］. Lab Med Clin（检验医学与临床），2020，17（15）：2232?2235.
[23]	Khiali S，Khani E，Entezari-Maleki T. A comprehensive review on tocilizumab in COVID-19 acute respiratory distress syndrome［J］. J Clin Pharmacol，2020，60（9）：1131?1146.
[24]	Tang MG，Ge ZJ，Lu JJ. Treatment progress of severe pneumonia ［J］. Hebei Med J（河北医药），2016，38（8）：1247?1249.
[25]	Qu JQ，Zheng Y，Yu R，et al. Discuss on the advantages and characteristics of Traditional Chinese Medicines in the treatment of pneumonia infected by novel coronavirus（论中医药防治新型冠状病毒感染的肺炎的优势与特色）［J/OL］. J Liaoning Univ Tradit Chin Med（辽宁中医药大学学报），2020. http：//kns.cnki.net/kcms/detail/21.1543.R.20200519.1555.020.html.
[26]	Wang HY，Mei GQ. Experience of Professor MEI guoqiang applying Chaihu Xianxiong decoction ［J］. J New Chin Med（新中医），2012，44（12）：180?181.
[27]	Wu ZQ，Yang L，Min N，et al. Effect of Qingzao Jiufei Decoction and its decomposing agent on MP infection Bax，Bcl-2，and Caspase-3［J］. Chin Tradit Herb Drugs（中草药），2018，49（2）：389?395.
[28]	Qiu T，Li WH，Zhang TT，et al. Distinct MET protein localization associated with MET exon 14 mutation types in patients with non-small-cell lung cancer［J］. Clin Lung Cancer，2018，19（4）：e391?e398.
[29]	Kotani H，Adachi Y，Kitai H，et al. Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers［J］. Oncogene，2018，37（13）：1775?1787.
[30]	Sun J，Shen JX. Research progress on relationship between inflammation and autophagy with acute lung injury［J］. Chin J Immunol（中国免疫学杂志），2019，17（35）：2163?2168.
[31]	Zhang XM，Li TS. Cytokine storm and immunotherapy for post-influenza pneumonia［J］. Med Recapitul（医学综述），2020，26（6）：1142?1146.
[32]	Li BT，Zhai XY，Li J，et al. Network pharmacology-based study on mechanisms of antipyretic action of Pueraria Radix［J］. Acta Pharm Sin（药学学报），2019，54（8）：1409?1416.
[33]	Wang YJ，Liu YS，Zhang M，et al. Inhibition of PTGS1 promotes osteogenic differentiation of adipose-derived stem cells by suppressing NF-kB signaling［J］. Stem Cell Res Ther，2019，10（1）：57.
[34]	Yuan A，Liu Q，Rao ZL，et al. Anti-inflammatory mechanism of main constituents in essential oil from Schizonepeta tenuifolia Briq. based on network pharmacology［J］. Chin Pharmacol Bull（中国药理学通报），2020，36（1）：97?103.
[35]	Tang Q，Chen S，Gao XD. Advances of mechanisms of metabolic memory-based diabetic complications and therapeutic drugs［J］. J China Pharm Univ（中国药科大学学报），2017，48（5）：622?628.
[36]	Yang CM，Yang ZX，Ma XL. The mechanism of AGEs-RAGE signaling pathway in diabetic nephropathy and the progress of Chinese medicine treatment［J］. Acta Chin Med（中医学报），2019，34（9）：1864?1868.
[37]	Lu Y，Chen Y，Wang YN，et al. Effect of Banxia Qinlian decoction on Th17/IL-17 immune inflammatory way of Sj?gren''''s Syndrome NOD model mice［J］. Chin J Integr Tradit West Med（中国中西医结合杂志），2015，35（5）：612?617.
[38]	Liang JJ，Lv J，Lu LR. The regulation and function of TCR signaling pathway［J］. Chin Bull Life Sci（生命科学），2016，28（2）：153?161.

[1]	WANG Yongjian, GUO Ming. Design, synthesis and structure-activity relationship of a series of novel BCR-ABL inhibitors[J]. Journal of China Pharmaceutical University, 2024, 55(3): 357-366. DOI: 10.11665/j.issn.1000-5048.2023042302
[2]	GUO Wei, XIE Chunwen, WANG Wensheng, ZHENG Deqiang, HE Shuwang. Synthesis of related substances of tebipenem pivoxil[J]. Journal of China Pharmaceutical University, 2018, 49(3): 286-290. DOI: 10.11665/j.issn.1000-5048.20180305
[3]	LUO Yan, GU Jinhua, LUO Zhiteng, WU Jie, YE Lianbao. Synthesis of the related substances of deferasirox[J]. Journal of China Pharmaceutical University, 2016, 47(3): 288-290. DOI: 10.11665/j.issn.1000-5048.20160306
[4]	YUAN Duo, ZHU Xiong, ZHANG Shijin, WANG Duo, LI Zhiyu, SUN Liping. Analysis and synthesis of the related substances of palbociclib[J]. Journal of China Pharmaceutical University, 2015, 46(6): 696-699. DOI: 10.11665/j.issn.1000-5048.20150610
[5]	ZHANG Changqing, FAN Rong, WANG Feng. Synthesis of two related substances of everolimus[J]. Journal of China Pharmaceutical University, 2015, 46(2): 174-177. DOI: 10.11665/j.issn.1000-5048.20150206
[6]	WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403
[7]	Synthesis of Dopexamine[J]. Journal of China Pharmaceutical University, 1999, (5): 328-331.
[8]	The Synthesis of Ba m buterol[J]. Journal of China Pharmaceutical University, 1999, (4): 11-12.
[9]	Synthesis of Oxendolone[J]. Journal of China Pharmaceutical University, 1997, (5): 8-11.
[10]	Synthesis of Sedative Temazepam[J]. Journal of China Pharmaceutical University, 1997, (4): 11-13.

Cited By

Get Citation

PDF

XML

Article views (256) PDF downloads (505)

Turn off MathJax

Article Contents

Abstract

References

Pharmacological mechanism of Qingfei Dayuan Granules for the treatment of pneumonia by network pharmacology

Abstract

References

Related Articles

Catalog

Pharmacological mechanism of Qingfei Dayuan Granules for the treatment of pneumonia by network pharmacology

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content